BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 14751087)

  • 1. Vascular targeting agents.
    Pilat MJ; McCormick J; LoRusso PM
    Curr Oncol Rep; 2004 Mar; 6(2):103-10. PubMed ID: 14751087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AVE8062: a new combretastatin derivative vascular disrupting agent.
    Delmonte A; Sessa C
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1541-8. PubMed ID: 19758109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular targeting agents as cancer therapeutics.
    Thorpe PE
    Clin Cancer Res; 2004 Jan; 10(2):415-27. PubMed ID: 14760060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular targeting therapy: potential benefit depends on tumor and host related effects.
    Horsman MR; Bohn AB; Busk M
    Exp Oncol; 2010 Sep; 32(3):143-8. PubMed ID: 21403608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of vascular disrupting agents and ionizing radiation.
    Clémenson C; Chargari C; Deutsch E
    Crit Rev Oncol Hematol; 2013 May; 86(2):143-60. PubMed ID: 23177097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current development status of small-molecule vascular disrupting agents.
    Chaplin DJ; Horsman MR; Siemann DW
    Curr Opin Investig Drugs; 2006 Jun; 7(6):522-8. PubMed ID: 16784022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupting tumour blood vessels.
    Tozer GM; Kanthou C; Baguley BC
    Nat Rev Cancer; 2005 Jun; 5(6):423-35. PubMed ID: 15928673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.
    Horsman MR; Siemann DW
    Cancer Res; 2006 Dec; 66(24):11520-39. PubMed ID: 17178843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular disrupting agents: a new class of drug in cancer therapy.
    Gaya AM; Rustin GJ
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):277-90. PubMed ID: 15997924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular-targeting agents and radiation therapy in lung cancer: where do we stand in 2005?
    Raben D; Ryan A
    Clin Lung Cancer; 2005 Nov; 7(3):175-9. PubMed ID: 16354311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular disrupting agents in clinical development.
    Hinnen P; Eskens FA
    Br J Cancer; 2007 Apr; 96(8):1159-65. PubMed ID: 17375046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first international conference on vascular targeting: meeting overview.
    Thorpe PE; Chaplin DJ; Blakey DC
    Cancer Res; 2003 Mar; 63(5):1144-7. PubMed ID: 12615734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies.
    Kanthou C; Tozer GM
    Int J Exp Pathol; 2009 Jun; 90(3):284-94. PubMed ID: 19563611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth.
    Pérez-Pérez MJ; Priego EM; Bueno O; Martins MS; Canela MD; Liekens S
    J Med Chem; 2016 Oct; 59(19):8685-8711. PubMed ID: 27348355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic strategies and agents in clinical trials.
    Rosen L
    Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combretastatins: more than just vascular targeting agents?
    Greene LM; Meegan MJ; Zisterer DM
    J Pharmacol Exp Ther; 2015 Nov; 355(2):212-27. PubMed ID: 26354991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targeting of the tumor vasculature.
    Tozer GM; Bicknell R
    Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of selected patents for cancer therapy targeting tumor angiogenesis.
    Kirstein MN; Moore MM; Dudek AZ
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):153-61. PubMed ID: 18221033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule vascular disrupting agents: potential new drugs for cancer treatment.
    Cai SX
    Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):79-101. PubMed ID: 18221055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer.
    McKeage MJ; Baguley BC
    Cancer; 2010 Apr; 116(8):1859-71. PubMed ID: 20166210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.